# Ampco Pittsburgh Corp: financial statements, quarterly

AP · NYSE · CIK 6176 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ap.md) · [Financials](/companies/ap/financials.md) · [Filings](/companies/ap/filings.md) · [Insiders](/companies/ap/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ap/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [102](/filings/0000950170-24-124716.md) | [104 d](/filings/0000950170-25-040259.md) | [110](/filings/0000950170-25-069330.md) | [107](/filings/0000950170-25-107413.md) | [92.1](/filings/0001193125-25-277803.md) | [97.7 d](/filings/0001193125-26-108598.md) | [99.2](/filings/0001193125-26-218133.md) | [109](/filings/0001193125-26-343321.md) | [104](/filings/0001193125-25-277803.md) | [104 d](/filings/0001193125-26-108598.md) | [103](/filings/0001193125-26-218133.md) | [97.9](/filings/0001193125-26-343321.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [11.8](/filings/0000950170-24-124716.md) | [12.8 d](/filings/0000950170-25-040259.md) | [13.0](/filings/0000950170-25-069330.md) | [13.6](/filings/0000950170-25-107413.md) | [13.3](/filings/0001193125-25-277803.md) | [15.0 d](/filings/0001193125-26-108598.md) | [13.7](/filings/0001193125-26-218133.md) | [13.0](/filings/0001193125-26-343321.md) | [12.7](/filings/0001193125-25-277803.md) | [12.8 d](/filings/0001193125-26-108598.md) | [13.9](/filings/0001193125-26-218133.md) | [12.9](/filings/0001193125-26-343321.md) |
| Operating income | $m | [1.7](/filings/0000950170-24-124716.md) | [(41.6) d](/filings/0000950170-25-040259.md) | [0.1](/filings/0000950170-25-069330.md) | [5.0](/filings/0000950170-25-107413.md) | [1.9](/filings/0001193125-25-277803.md) | [5.2 d](/filings/0001193125-26-108598.md) | [3.9](/filings/0001193125-26-218133.md) | [(3.1)](/filings/0001193125-26-343321.md) | [1.1](/filings/0001193125-25-277803.md) | [(56.4) d](/filings/0001193125-26-108598.md) | [2.6](/filings/0001193125-26-218133.md) | [5.1](/filings/0001193125-26-343321.md) |
| Income tax | $m | [0.1](/filings/0000950170-24-124716.md) | [(1.7) d](/filings/0000950170-25-040259.md) | [0.5](/filings/0000950170-25-069330.md) | [0.9](/filings/0000950170-25-107413.md) | [0.6](/filings/0001193125-25-277803.md) | [0.7 d](/filings/0001193125-26-108598.md) | [0.1](/filings/0001193125-26-218133.md) | [0.6](/filings/0001193125-26-343321.md) | [0.5](/filings/0001193125-25-277803.md) | [(1.1) d](/filings/0001193125-26-108598.md) | [0.6](/filings/0001193125-26-218133.md) | [0.7](/filings/0001193125-26-343321.md) |
| Net income | $m | [0.8](/filings/0000950170-24-124716.md) | [(41.8) d](/filings/0000950170-25-040259.md) | [(2.7)](/filings/0000950170-25-069330.md) | [2.0](/filings/0000950170-25-107413.md) | [(2.0)](/filings/0001193125-25-277803.md) | [3.1 d](/filings/0001193125-26-108598.md) | [1.1](/filings/0001193125-26-218133.md) | [(7.3)](/filings/0001193125-26-343321.md) | [(2.2)](/filings/0001193125-25-277803.md) | [(57.7) d](/filings/0001193125-26-108598.md) | [(0.9)](/filings/0001193125-26-218133.md) | [1.5](/filings/0001193125-26-343321.md) |
| Diluted EPS | $ per share | [0.04](/filings/0000950170-24-124716.md) | not reported | [(0.14)](/filings/0000950170-25-069330.md) | [0.10](/filings/0000950170-25-107413.md) | [(0.10)](/filings/0001193125-25-277803.md) | not reported | [0.06](/filings/0001193125-26-218133.md) | [(0.36)](/filings/0001193125-26-343321.md) | [(0.11)](/filings/0001193125-25-277803.md) | not reported | [(0.04)](/filings/0001193125-26-218133.md) | [0.07](/filings/0001193125-26-343321.md) |
| Basic EPS | $ per share | [0.04](/filings/0000950170-24-124716.md) | not reported | [(0.14)](/filings/0000950170-25-069330.md) | [0.10](/filings/0000950170-25-107413.md) | [(0.10)](/filings/0001193125-25-277803.md) | not reported | [0.06](/filings/0001193125-26-218133.md) | [(0.36)](/filings/0001193125-26-343321.md) | [(0.11)](/filings/0001193125-25-277803.md) | not reported | [(0.04)](/filings/0001193125-26-218133.md) | [0.07](/filings/0001193125-26-343321.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.1](/filings/0000950170-23-063377.md) | [7.3](/filings/0000950170-25-040259.md) | [10.8](/filings/0000950170-24-058689.md) | [7.9](/filings/0000950170-24-095513.md) | [11.8](/filings/0000950170-24-124716.md) | [15.4](/filings/0001193125-26-108598.md) | [7.1](/filings/0000950170-25-069330.md) | [9.9](/filings/0000950170-25-107413.md) | [15.0](/filings/0001193125-25-277803.md) | [10.7](/filings/0001193125-26-343321.md) | [9.2](/filings/0001193125-26-218133.md) | [7.0](/filings/0001193125-26-343321.md) |
| Current assets | $m | [243](/filings/0000950170-23-063377.md) | [237](/filings/0000950170-25-040259.md) | [244](/filings/0000950170-24-058689.md) | [247](/filings/0000950170-24-095513.md) | [239](/filings/0000950170-24-124716.md) | [237](/filings/0001193125-26-108598.md) | [246](/filings/0000950170-25-069330.md) | [251](/filings/0000950170-25-107413.md) | [250](/filings/0001193125-25-277803.md) | [240](/filings/0001193125-26-343321.md) | [249](/filings/0001193125-26-218133.md) | [248](/filings/0001193125-26-343321.md) |
| Total assets | $m | [506](/filings/0000950170-23-063377.md) | [566](/filings/0000950170-25-040259.md) | [566](/filings/0000950170-24-058689.md) | [561](/filings/0000950170-24-095513.md) | [547](/filings/0000950170-24-124716.md) | [531](/filings/0001193125-26-108598.md) | [536](/filings/0000950170-25-069330.md) | [537](/filings/0000950170-25-107413.md) | [524](/filings/0001193125-25-277803.md) | [495](/filings/0001193125-26-343321.md) | [497](/filings/0001193125-26-218133.md) | [491](/filings/0001193125-26-343321.md) |
| Current liabilities | $m | [119](/filings/0000950170-23-063377.md) | [117](/filings/0000950170-25-040259.md) | [126](/filings/0000950170-24-058689.md) | [125](/filings/0000950170-24-095513.md) | [120](/filings/0000950170-24-124716.md) | [125](/filings/0001193125-26-108598.md) | [133](/filings/0000950170-25-069330.md) | [140](/filings/0000950170-25-107413.md) | [136](/filings/0001193125-25-277803.md) | [130](/filings/0001193125-26-343321.md) | [142](/filings/0001193125-26-218133.md) | [140](/filings/0001193125-26-343321.md) |
| Total liabilities | $m | [392](/filings/0000950170-23-063377.md) | [494](/filings/0000950170-25-040259.md) | [499](/filings/0000950170-24-058689.md) | [491](/filings/0000950170-24-095513.md) | [474](/filings/0000950170-24-124716.md) | [460](/filings/0001193125-26-108598.md) | [459](/filings/0000950170-25-069330.md) | [461](/filings/0000950170-25-107413.md) | [450](/filings/0001193125-25-277803.md) | [447](/filings/0001193125-26-343321.md) | [450](/filings/0001193125-26-218133.md) | [443](/filings/0001193125-26-343321.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [104](/filings/0000950170-23-063377.md) | [60.9](/filings/0000950170-25-040259.md) | [56.3](/filings/0000950170-24-058689.md) | [58.0](/filings/0000950170-24-095513.md) | [61.3](/filings/0000950170-24-124716.md) | [58.9](/filings/0001193125-26-108598.md) | [64.6](/filings/0000950170-25-069330.md) | [62.7](/filings/0000950170-25-107413.md) | [60.1](/filings/0001193125-25-277803.md) | [32.6](/filings/0001193125-26-343321.md) | [31.3](/filings/0001193125-26-218133.md) | [31.1](/filings/0001193125-26-343321.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.2) d](/filings/0000950170-24-124716.md) | [6.6 d](/filings/0000950170-25-040259.md) | [4.5](/filings/0000950170-25-069330.md) | [(5.3) d](/filings/0000950170-25-107413.md) | [11.4 d](/filings/0001193125-25-277803.md) | [7.5 d](/filings/0001193125-26-108598.md) | [(5.3)](/filings/0001193125-26-218133.md) | [(2.3) d](/filings/0001193125-26-343321.md) | [6.3 d](/filings/0001193125-25-277803.md) | [2.7 d](/filings/0001193125-26-108598.md) | [1.6](/filings/0001193125-26-218133.md) | [0.3 d](/filings/0001193125-26-343321.md) |
| Capital expenditure | $m | [4.1 d](/filings/0000950170-24-124716.md) | [6.3 d](/filings/0000950170-25-040259.md) | [2.8](/filings/0000950170-25-069330.md) | [2.7 d](/filings/0000950170-25-107413.md) | [2.9 d](/filings/0001193125-25-277803.md) | [3.8 d](/filings/0001193125-26-108598.md) | [2.2](/filings/0001193125-26-218133.md) | [1.5 d](/filings/0001193125-26-343321.md) | [3.0 d](/filings/0001193125-25-277803.md) | [2.8 d](/filings/0001193125-26-108598.md) | [3.4](/filings/0001193125-26-218133.md) | [5.7 d](/filings/0001193125-26-343321.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0000950170-23-063377.md) | [19.4](/filings/0000950170-24-058689.md) | [19.6](/filings/0000950170-24-095513.md) | [19.7](/filings/0000950170-24-124716.md) | [19.7](/filings/0000950170-25-069330.md) | [19.9](/filings/0000950170-25-107413.md) | [20.0](/filings/0001193125-25-277803.md) | [20.2](/filings/0001193125-26-218133.md) | [20.1](/filings/0001193125-26-343321.md) | [20.2](/filings/0001193125-25-277803.md) | [20.2](/filings/0001193125-26-218133.md) | [21.4](/filings/0001193125-26-343321.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,658,621 at 2026-08-06, from the cover of the [10-Q filed 2026-08-11](/filings/0001193125-26-343321.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.